Answer
Yes, both active ingredients in co-amoxiclav—amoxicillin and clavulanic acid—pass into breast milk; clavulanic acid’s effects on the infant are unknown, diarrhoea, mucosal fungal infection and sensitisation are possible, breastfeeding may need to stop, and use requires the treating physician’s benefit–risk assessment.
Sources for this answer
- Augmentin 125/31 SuspensionGlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 20Document updated
Sources checked